Clinical Trial Update: Visceral Adiposity and CVD Risk in Women

View source ↗

Summary

A completed NHLBI-sponsored clinical trial examining visceral adiposity and cardiovascular risk in women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Diabetes Mellitus
• Heart Disease
• Obesity

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Heart Diseases | Status: COMPLETED